Page last updated: 2024-09-04

ezetimibe and Chronic Hepatitis C

ezetimibe has been researched along with Chronic Hepatitis C in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Azhar, A; Balaraman, V; Bhalla, A; Binari, LA; Concepcion, BP; Eason, JD; Forbes, RC; Hall, IE; Joglekar, K; Molnar, MZ; Rofaiel, G; Shaffer, D; Talwar, M; Tsujita, M1
Alba, C; Bahinskaya, I; Cerrochi, O; Cypel, M; Dahari, H; Feld, JJ; Hansen, BE; Humar, A; Janssen, HLA; Kamkar, N; Keshavjee, S; Kim, SJ; Kumar, D; Marks, N; McDonald, M; Onofrio, FQ; Pinto Ribeiro, RV; Reichman, TW; Sapisochin, G; Schiff, J; Selzner, M; Singer, LG; Tinckam, K; Waddell, TK; Zahoor, MA1
Chung, RT; Holmes, JA1
Abd-Ellah, MF; Gad, MA; Helal, GK; Mahgoup, EM1
Soza, A1
Nash, DT1

Trials

2 trial(s) available for ezetimibe and Chronic Hepatitis C

ArticleYear
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study.
    The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:7

    Topics: Adult; Aged; Anticholesteremic Agents; Antiviral Agents; Benzimidazoles; Canada; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ezetimibe; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Pyrrolidines; Quinoxalines; RNA Viruses; Sulfonamides; Tissue Donors; Transplant Recipients; Transplants; Viral Load

2020
Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:5

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Egypt; Ezetimibe; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Obesity; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Single-Blind Method; Time Factors; Treatment Outcome; Viral Load; Virus Internalization

2016

Other Studies

4 other study(ies) available for ezetimibe and Chronic Hepatitis C

ArticleYear
Association between ezetimibe usage and hepatitis C RNA levels in uninfected kidney transplant recipients who received hepatitis C infected kidneys.
    Clinical transplantation, 2021, Volume: 35, Issue:12

    Topics: Antiviral Agents; Ezetimibe; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Kidney; Kidney Transplantation; Retrospective Studies; RNA; Tissue Donors; Transplant Recipients

2021
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantation.
    The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:7

    Topics: Antiviral Agents; Ezetimibe; Hepatitis C; Hepatitis C, Chronic; Humans; Organ Transplantation

2020
Hepatitis C RNA clearance after treatment with ezetimibe.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:8

    Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Middle Aged; RNA, Viral

2012
A statin for a patient with hyperlipidemia and hepatitis C?
    Postgraduate medicine, 2004, Volume: 115, Issue:5

    Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Cholestyramine Resin; Diet; Exercise; Ezetimibe; Hepatitis C, Chronic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pyrroles; Risk Factors

2004